745 Immune cell profiling of advanced-stage solid tumors patients treated with an oncolytic adenovirus encoding for TNF-a and IL-2 (TILT-123)

• Tuomo Alanko,
• Akseli Hemminki,
• Víctor Cervera-Carrascón,
• João Santos,
• Riikka Havunen,
• Juha Kononen,
• Jorma Sormunen,
• Katriina Peltola,
• Riitta Korpisaari,
• Susanna Juteau,
• Marjut Jaakkola,
• Suvi Sorsa,
• Santeri A Pakola,
• James Clubb,
• Elise Jirovec,
• Dafne CA Quixabeira,
• Tatiana Kudling,
• Lyna Haybout,
• Claudia Kistler

Affiliations

Tuomo Alanko

4Docrates Cancer Center, Helsinki, Finland

Akseli Hemminki

1TILT Biotherapeutics, Helsinki, Finland

Víctor Cervera-Carrascón

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

João Santos

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Riikka Havunen

1TILT Biotherapeutics, Helsinki, Finland

Juha Kononen

4Docrates Cancer Center, Helsinki, Finland

Jorma Sormunen

4Docrates Cancer Center, Helsinki, Finland

Katriina Peltola

3Comprehensive Cancer Centre, Helsinki, Finland

Riitta Korpisaari

4Docrates Cancer Center, Helsinki, Finland

Susanna Juteau

6Helsinki University Hospital, Helsinki, Finland

Marjut Jaakkola

4Docrates Cancer Center, Helsinki, Finland

Suvi Sorsa

1TILT Biotherapeutics, Helsinki, Finland

Santeri A Pakola

5University of Helsinki, Helsinki, Finland

James Clubb

1TILT Biotherapeutics, Helsinki, Finland

Elise Jirovec

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Dafne CA Quixabeira

2Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Tatiana Kudling

1Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Lyna Haybout

1TILT Biotherapeutics, Helsinki, Finland

Claudia Kistler

1TILT Biotherapeutics, Helsinki, Finland